Circulating tumor DNA (ctDNA) from a phase II study of adjuvant dostarlimab with pelvic radiation in locally advanced, mismatch repair–deficient (MMR-D) endometrial cancer (D-RT study).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Gabriela Sotolongo, David N. Brown, Maria M. Rubinstein, Robin Guo, Qin Zhou, Alexia Iasonos, Seth M. Cohen, William P. Tew, Sminu Bose, Alison M. Schram, Vicky Makker, M. Herman Chui, Marisa Kollmeier, Nadeem Abu-Rustum, Roisin Eilish O'Cearbhaill, Dmitriy Zamarin, Carol Aghajanian, Kaled M. Alektiar, Britta Weigelt, Ying L. Liu
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162521364
Cites:
Cited by:
Related to: